Terms of Use

Welcome to a website of Aadi Bioscience, Inc. (“Aadi”). By using the site, you agree to be bound by the following terms and all applicable laws and regulations. If you do not agree to these Terms of Use, you are not permitted to use the site. The information provided on this website is presented in summary form, is general in nature, and is provided for informational purposes only. The information on this site is intended only for the purpose of helping patients and family members better understand certain health conditions and treatment options. The content is not intended in any way to be a substitute for professional medical advice and should not be interpreted as treatment recommendations. Only a physician who has had an opportunity to interact with the patient in person, with access to the patient’s records and the opportunity to conduct appropriate follow-up, can provide recommendations for treatment.

Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Neither the content nor any other service offered by or through this website is intended to be relied on for medical diagnosis or treatment, without a physician’s interaction and involvement. Never disregard medical advice or delay in seeking it because of something you have read on this website.

THIS SITE AND THE CONTENT ARE PROVIDED “AS IS”. AADI, ITS LICENSORS, AND ITS SUPPLIERS, TO THE FULLEST EXTENT PERMITTED BY LAW, DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR PARTICULAR PURPOSE. SPECIFICALLY, AADI, ITS LICENSORS, AND ITS SUPPLIERS MAKE NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS, CURRENTNESS, SUITABILITY OR TIMELINESS OF THE CONTENT, SOFTWARE, TEXT, GRAPHICS, TOOLS, LINKS, OR COMMUNICATIONS PROVIDED ON OR THROUGH THE USE OF THE WEBSITE OR AADI, OR ON ANY SITE OR SITES “LINKED” TO THIS SITE. AADI MAKES NO WARRANTY THAT THE SITE WILL BE AVAILABLE, UNINTERRUPTED, ERROR FREE, OR FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS.

TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL AADI, ITS LICENSORS, ITS SUPPLIERS, OR ANY THIRD PARTIES MENTIONED ON THE WEBSITE BE LIABLE FOR ANY DAMAGES (INCLUDING, WITHOUT LIMITATION, INCIDENTAL AND CONSEQUENTIAL DAMAGES, PERSONAL INJURY/WRONGFUL DEATH, LOST PROFITS, OR DAMAGES RESULTING FROM LOST DATA OR BUSINESS INTERRUPTION) RESULTING FROM THE USE OR INABILITY TO USE THE WEBSITE OR THE CONTENT OR ANY FAILURE OF PERFORMANCE, ERROR, OMISSION, INTERRUPTION, EFFECT, DELAY IN OPERATION OR TRANSMISSION, COMPUTER VIRUS, LINE SYSTEM FAILURE, LOSS OF DATA, OR LOSS OF USE RELATED TO THE SITE OR ANY WEB SITE OPERATED BY ANY THIRD PARTY, WHETHER BASED ON WARRANTY, CONTRACT, TORT, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT AADI IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IF YOU ARE DISSATISFIED WITH US, ANY OF OUR SERVICES OR THESE TERMS OF USE, YOUR SOLE AND EXCLUSIVE REMEDY IS TO DISCONTINUE USE OF THE SITE.

Any claims arising in connection with your use of the site or any content must be brought within one (1) year of the date of the event giving rise to such action occurred.

As a resource to our visitors, this site provides links to other web sites. However, because we do not control the content of the other websites we may link to, and due to their constantly changing nature, we cannot be responsible for the content, practices or standards of third-party sites. Aadi does not endorse the content on any third-party websites. Aadi is not responsible for the content of linked third-party sites, sites framed within the site, or third-party advertisements, and does not make any representations regarding their content or accuracy. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Everything that you read or see on the site is copyrighted or otherwise protected and owned by the Aadi or a third party who licensed or granted to Aadi the right to use such material. Unless otherwise expressly noted, nothing that you read or see on the site may be copied or used except as provided in these Terms of Use or with the prior written approval of Aadi.

We grant you permission to print individual pages from the site, unless otherwise expressly noted, for your own personal, non-commercial use in learning about the services or products offered by Aadi or for your non-commercial use in connection with health care or education. If you are a health care professional or provider, you may print individual pages from the site, unless otherwise expressly noted, and share the information and materials with others. No other permission is granted to you to print, copy, reproduce, distribute, license, transfer, sale, transmit, upload, download, store, display in public, alter, modify or create derivative works of these materials. This grant of permission is not a transfer of title, and under this permission you may not:

  • use the materials for any commercial purpose, or for any public display (commercial or non-commercial);
  • remove any copyright, trademark or other proprietary notations from the materials; or
  • transfer the materials to another person or “mirror” the materials on any other server.

We make no warranties or representations to you that your use of any materials displayed on the site will not infringe the rights of third parties.

Unless otherwise indicated, all logos, names, designs, and marks on the site are trademarks or service marks owned or used under license by Aadi. The use or misuse of any of these marks or other information is strictly prohibited. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent or trademark of Aadi or any third party.

Except as expressly provided above nothing contained herein shall be construed as conferring any license or right under any Aadi copyright. Except as expressly set forth on the site, if you submit any information to us, including any comments, remarks, suggestions, ideas, notes, drawings, graphics, concepts, or other information, you are giving that information, and all your rights in it, to Aadi free of charge and such information shall be deemed to be non-confidential and Aadi shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose and distribute the information to others without limitation, without your consent or any compensation to you or anyone else. Aadi shall be free to use any know-how or techniques contained in such information for any purpose whatsoever including but not limited to developing, manufacturing and marketing products incorporating such information. This is true whether you submit such information to us by email, through a form on the site, on a bulletin board, or in any other manner. Aadi may from time to time monitor, review and, in its sole discretion, modify or delete any postings you make on the site however, Aadi is not obligated to do so.

You agree not to submit or transmit any material that is unlawful, threatening, libelous, defamatory, obscene, pornographic, profane, or might in any other way violate any law, regulation, or rule. You are solely responsible for any material you submit to the site. You further agree not to upload, email, post or transmit to, or distribute or otherwise publish through the site any material which disrupts the normal operation of the site, including posting or otherwise transmitting material that is not related to the subject at issue or otherwise restricts or inhibits any other user from using the site. Through your usage of the site, you may submit and/or Aadi may gather certain limited information about you and your web site usage. We are free to use such information for any purpose we deem appropriate, including marketing purposes.

To obtain full access to the site, you may be required to complete a registration. You are responsible for maintaining the confidentiality of your account and password and for restricting access to your computer. You accept responsibility for all activities that occur under your account or password and such use shall be deemed to be use by you. You will ensure that all use of your account fully complies with these Terms of Use. Transfer of the account by you to any other person or entity is prohibited.

When using the site, information will be transmitted over a medium that is beyond the control and jurisdiction of Aadi and its suppliers. Accordingly, Aadi assumes no liability for or relating to the delay, failure, interruption, or corruption of any data or other information transmitted in connection with use of this site.

Aadi is located in Pacific Palisades, California, in the United States of America (USA). This site is intended for the exclusive use of residents of the USA. Aadi makes no representation that the materials on the site are appropriate or available for use in other locations. Access to the content may not be legal by certain persons or in certain countries outside of the USA. If you access this site from outside the United States, you do so at your own risk and are responsible for compliance with the laws of your jurisdiction.

These Terms of Use are governed by the internal substantive laws of the State of California, without resort to its conflict of laws principles. If any provision of these Terms of Use is found to be invalid by any court having competent jurisdiction, the invalidity of such provision shall not affect the validity of the remaining provisions of these Terms of Use. You expressly agree that exclusive jurisdiction for any dispute with Aadi, or in any way relating to your use of this site, resides in the courts of the State of California. Aadi may modify these Terms of Use at any time without notice to you. Aadi may terminate this agreement, terminate your access to all or part of the site, or suspend any user’s access to all or part of the site, at any time, without notice to you, if it believes, in its sole judgment, that you have breached or may breach any term or condition of this agreement, or for its convenience. You may terminate this agreement at any time by destroying all materials received from the site and ceasing to use the site.

Except as expressly provided in a particular “legal notice” on this site, these Terms of Use constitute the entire agreement between you and Aadi with respect to the use of this site, and content. Your use of this site is also subject to the Privacy Statement on this website.

Indication

FYARRO (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors in adult patients.

Important Safety Information

How is FYARRO taken?
FYARRO is administered by intravenous infusion into your vein over 30 minutes on Days 1 and 8 of each 21-day cycle until disease progression or unacceptable toxicity.

Who should not receive FYARRO?

Do not use FYARRO if you have had a severe allergic reaction to sirolimus or human albumin. You should tell your health care provider before receiving FYARRO if you are allergic to sirolimus (Rapamune®), everolimus (Afinitor®), temsirolimus (Torisel®) or Human Albumin.

What are the possible side effects of FYARRO?

FYARRO can cause serious side effects, including the following:

Mouth ulcers and sores

Mouth ulcers and sores are common during treatment with FYARRO and can be severe. When you start treatment with FYARRO, your health care provider may also prescribe an alcohol-free mouthwash to reduce the likelihood of getting mouth ulcers or sores and to reduce their severity. Follow your health care provider’s instructions on how to use this prescription mouthwash. If you develop pain, discomfort, or open sores in your mouth, tell your health care provider. Your health care provider may tell you to restart this mouthwash or to use a special mouthwash or mouth gel that does not contain alcohol, peroxide, iodine, or thyme.

Decreased blood cell counts

FYARRO can cause you to have decreased red blood cells, platelets, and white blood cells. Your health care provider should do blood tests to check your blood cell counts before you start and during treatment with FYARRO.

Infections

Infections such as pneumonia, or a bacterial, fungal, or viral infection may develop while on treatment with FYARRO. Viral infections may include active hepatitis B in people who have had hepatitis B in the past (reactivation). In some people (including adults and children), these infections may be severe and can lead to death. If infections occur, urgent treatment may be required. Tell your health care provider right away if you have a temperature of 100.5°F or above, have chills, or do not feel well. Symptoms of hepatitis B or infection may include the following: fever, chills, skin rash, joint pain and swelling, tiredness, loss of appetite, nausea, pale stools or dark urine, yellowing of the skin, or pain in the upper right side of the stomach.

Low potassium

FYARRO can cause your blood potassium levels to fall. Low blood potassium levels can make you feel weak and can affect your heart rhythm if severe. Your health care provider should do blood tests to check your potassium levels before you start and during treatment with FYARRO.

Increased blood sugar and fat (cholesterol and triglyceride) levels in blood

Your health care provider should do blood tests to check your fasting blood sugar, cholesterol, and triglyceride levels in the blood before you start and during treatment with FYARRO. Diabetic patients should monitor their fasting serum glucose more frequently.

Lung inflammation

FYARRO can cause inflammation of the lung. If you develop a persistent cough, chest pain, or shortness of breath, let your doctor know right away.

Bleeding

FYARRO can cause serious and sometimes fatal bleeding. If you develop bleeding, let your doctor know right away.

Severe allergic reactions

Call your health care provider or get medical help right away if you get signs and symptoms of a severe allergic reaction including rash, itching, hives, difficulty breathing or swallowing, flushing, chest pain, or dizziness.

Harm to an unborn child

FYARRO can cause harm to your unborn baby. For women who are able to become pregnant, your health care provider will give you a pregnancy test before you start treatment with FYARRO. You should use effective birth control during treatment and for 12 weeks after your last dose of FYARRO. Men with a female partner should use effective birth control during treatment and for 12 weeks after your last dose of FYARRO.

Infertility

FYARRO may affect fertility in woman and men and may affect your ability to become pregnant if you are female, or your ability to father a child if you are male. Talk to your health care provider if this is a concern for you.

Breastfeeding

Do not breastfeed during treatment and for 2 weeks after your last dose.

Vaccinations

You should not receive a live vaccine or be around people who have recently received a live vaccine during your treatment with FYARRO. If you are not sure about the type of vaccine, ask your health care provider.

Human albumin

Human serum albumin (HSA), an ingredient in FYARRO, is made from human blood. The blood donors for HSA are checked for infections and the HSA is processed to get rid of germs in the product. Because of these steps, HSA carries only an extremely small risk for transmission of viral diseases and “mad cow” disease, also called variant Creutzfeldt-Jakob disease (vCJD). No cases of transmission of viral diseases, CJD, or vCJD have ever been identified for licensed albumin.

The most common side effects with FYARRO include the following:

  • Mouth ulcers or sores
  • Feeling weak or tired
  • Rash
  • Infection
  • Nausea
  • Swelling of arms, hands, feet, ankles, face, or other parts of the body
  • Diarrhea
  • Body pain
  • Decreased weight
  • Decreased appetite
  • Cough
  • Vomiting
  • Altered taste

Other possible side effects that may occur with FYARRO:

  • Absence of menstrual periods (menstruation). You may miss 1 or more menstrual period. Tell your health care provider if this happens

What should I tell my health care provider before taking FYARRO?

Before taking FYARRO, tell your health care provider about all your medical conditions, including if you:

• Have or have had kidney problems
• Have or have had liver problems
• Have diabetes or high blood sugar
• Have high blood cholesterol levels
• Have any infections
• Previously had hepatitis B

Tell your health care provider about all of the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Using FYARRO with certain other medicines can cause serious side effects. Keep a list of medicines you take and show it to your health care provider when you get a new medicine. Especially tell your health care provider if you take the following:

• St John’s wort (Hypericum perforatum)
• Medicine for:
  — Fungal infections
  — Bacterial infections
  — Tuberculosis
  — Seizures
  — HIV-AIDS
  — Heart conditions or high blood pressure

  • Medicines that weaken the immune system (your body’s ability to fight infections and other diseases)

Ask your health care provider or pharmacist if you are not sure if your medicine is one of those taken for the conditions listed above. If you are taking any medicines for the conditions listed above, your health care provider might need to prescribe a different medicine or your dose of FYARRO may need to be changed. Tell your health care provider before you start taking any new medicine.

What should I do if I receive FYARRO from my health care provider?

You should not drink grapefruit juice or eat grapefruit during your treatment with FYARRO. It may make the amount of FYARRO in your blood increase to a harmful level.

Tell your health care provider if you have any side effect that bothers you or does not go away.

These are not all the possible side effects of FYARRO. For more information, ask your health care provider or pharmacist. Call your doctor for medical advice about side effects.

The risk information provided here is not comprehensive. To learn more, talk about FYARRO with your health care provider or pharmacist. The FDA-approved product labeling can be found at www.FYARRO.com or 1-888-BIO-AADI.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information.

Indication

FYARRO (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors in adult patients.

Indication
Important Safety Information

How is FYARRO taken?
FYARRO is administered by intravenous infusion into your vein over 30 minutes on Days 1 and 8 of each 21-day cycle until disease progression or unacceptable toxicity.

Who should not receive FYARRO?

Do not use FYARRO if you have had a severe allergic reaction to sirolimus or human albumin. You should tell your health care provider before receiving FYARRO if you are allergic to sirolimus (Rapamune®), everolimus (Afinitor®), temsirolimus (Torisel®) or Human Albumin.

What are the possible side effects of FYARRO?

FYARRO can cause serious side effects, including the following:

Mouth ulcers and sores

Mouth ulcers and sores are common during treatment with FYARRO and can be severe. When you start treatment with FYARRO, your health care provider may also prescribe an alcohol-free mouthwash to reduce the likelihood of getting mouth ulcers or sores and to reduce their severity. Follow your health care provider’s instructions on how to use this prescription mouthwash. If you develop pain, discomfort, or open sores in your mouth, tell your health care provider. Your health care provider may tell you to restart this mouthwash or to use a special mouthwash or mouth gel that does not contain alcohol, peroxide, iodine, or thyme.

Decreased blood cell counts

FYARRO can cause you to have decreased red blood cells, platelets, and white blood cells. Your health care provider should do blood tests to check your blood cell counts before you start and during treatment with FYARRO.

Infections

Infections such as pneumonia, or a bacterial, fungal, or viral infection may develop while on treatment with FYARRO. Viral infections may include active hepatitis B in people who have had hepatitis B in the past (reactivation). In some people (including adults and children), these infections may be severe and can lead to death. If infections occur, urgent treatment may be required. Tell your health care provider right away if you have a temperature of 100.5°F or above, have chills, or do not feel well. Symptoms of hepatitis B or infection may include the following: fever, chills, skin rash, joint pain and swelling, tiredness, loss of appetite, nausea, pale stools or dark urine, yellowing of the skin, or pain in the upper right side of the stomach.

Low potassium

FYARRO can cause your blood potassium levels to fall. Low blood potassium levels can make you feel weak and can affect your heart rhythm if severe. Your health care provider should do blood tests to check your potassium levels before you start and during treatment with FYARRO.

Increased blood sugar and fat (cholesterol and triglyceride) levels in blood

Your health care provider should do blood tests to check your fasting blood sugar, cholesterol, and triglyceride levels in the blood before you start and during treatment with FYARRO. Diabetic patients should monitor their fasting serum glucose more frequently.

Lung inflammation

FYARRO can cause inflammation of the lung. If you develop a persistent cough, chest pain, or shortness of breath, let your doctor know right away.

Bleeding

FYARRO can cause serious and sometimes fatal bleeding. If you develop bleeding, let your doctor know right away.

Severe allergic reactions

Call your health care provider or get medical help right away if you get signs and symptoms of a severe allergic reaction including rash, itching, hives, difficulty breathing or swallowing, flushing, chest pain, or dizziness.

Harm to an unborn child

FYARRO can cause harm to your unborn baby. For women who are able to become pregnant, your health care provider will give you a pregnancy test before you start treatment with FYARRO. You should use effective birth control during treatment and for 12 weeks after your last dose of FYARRO. Men with a female partner should use effective birth control during treatment and for 12 weeks after your last dose of FYARRO.

Infertility

FYARRO may affect fertility in woman and men and may affect your ability to become pregnant if you are female, or your ability to father a child if you are male. Talk to your health care provider if this is a concern for you.

Breastfeeding

Do not breastfeed during treatment and for 2 weeks after your last dose.

Vaccinations

You should not receive a live vaccine or be around people who have recently received a live vaccine during your treatment with FYARRO. If you are not sure about the type of vaccine, ask your health care provider.

Human albumin

Human serum albumin (HSA), an ingredient in FYARRO, is made from human blood. The blood donors for HSA are checked for infections and the HSA is processed to get rid of germs in the product. Because of these steps, HSA carries only an extremely small risk for transmission of viral diseases and “mad cow” disease, also called variant Creutzfeldt-Jakob disease (vCJD). No cases of transmission of viral diseases, CJD, or vCJD have ever been identified for licensed albumin.

The most common side effects with FYARRO include the following:

  • Mouth ulcers or sores
  • Feeling weak or tired
  • Rash
  • Infection
  • Nausea
  • Swelling of arms, hands, feet, ankles, face, or other parts of the body
  • Diarrhea
  • Body pain
  • Decreased weight
  • Decreased appetite
  • Cough
  • Vomiting
  • Altered taste

Other possible side effects that may occur with FYARRO:

  • Absence of menstrual periods (menstruation). You may miss 1 or more menstrual period. Tell your health care provider if this happens

What should I tell my health care provider before taking FYARRO?

Before taking FYARRO, tell your health care provider about all your medical conditions, including if you:

  • Have or have had kidney problems
  • Have or have had liver problems
  • Have diabetes or high blood sugar
  • Have high blood cholesterol levels
  • Have any infections
  • Previously had hepatitis B

Tell your health care provider about all of the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Using FYARRO with certain other medicines can cause serious side effects. Keep a list of medicines you take and show it to your health care provider when you get a new medicine. Especially tell your health care provider if you take the following:

  • St John’s wort (Hypericum perforatum)
  • Medicine for:
      — Fungal infections
      — Bacterial infections
      — Tuberculosis
      — Seizures
      — HIV-AIDS
      — Heart conditions or high blood pressure
  • Medicines that weaken the immune system (your body’s ability to fight infections and other diseases)

Ask your health care provider or pharmacist if you are not sure if your medicine is one of those taken for the conditions listed above. If you are taking any medicines for the conditions listed above, your health care provider might need to prescribe a different medicine or your dose of FYARRO may need to be changed. Tell your health care provider before you start taking any new medicine.

What should I do if I receive FYARRO from my health care provider?

You should not drink grapefruit juice or eat grapefruit during your treatment with FYARRO. It may make the amount of FYARRO in your blood increase to a harmful level.

Tell your health care provider if you have any side effect that bothers you or does not go away.

These are not all the possible side effects of FYARRO. For more information, ask your health care provider or pharmacist. Call your doctor for medical advice about side effects.

The risk information provided here is not comprehensive. To learn more, talk about FYARRO with your health care provider or pharmacist. The FDA-approved product labeling can be found at www.FYARRO.com or 1-888-BIO-AADI.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information.

Indication

FYARRO (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors in adult patients.